These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36043326)

  • 21. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
    Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
    JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Kubo T; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Otake H; Kozuma K; Ioji T; Kaneda H; Serikawa T; Kataoka T; Okada H; Akasaka T;
    Eur Heart J; 2017 Nov; 38(42):3139-3147. PubMed ID: 29121226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial.
    Xu B; Yang Y; Yuan Z; Du Z; Wong SC; Généreux P; Lu S;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):664-70. PubMed ID: 23523240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Bifurcation Angles in Left Main Bifurcation Intervention Using a Two-Stent Technique.
    Ki YJ; Jung JH; Han JK; Hong S; Cho JH; Gwon HC; Lee SY; Rhew JY; Chae JK; Chae IH; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    J Interv Cardiol; 2020; 2020():2475930. PubMed ID: 32733170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    de Filippo O; Bruno F; Pinxterhuis TH; Gąsior M; Perl L; Gaido L; Tuttolomondo D; Greco A; Verardi R; Lo Martire G; Iannaccone M; Leone A; Liccardo G; Caglioni S; González Ferreiro R; Rodinò G; Musumeci G; Patti G; Borzillo I; Tarantini G; Wańha W; Casella B; Ploumen EH; Pyka Ł; Kornowski R; Gagnor A; Piccolo R; Roubin SR; Capodanno D; Zocca P; Conrotto F; De Ferrari GM; von Birgelen C; D'Ascenzo F;
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):221-232. PubMed ID: 37232278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.
    Muramatsu T; Ozaki Y; Nanasato M; Ishikawa M; Nagasaka R; Ohota M; Hashimoto Y; Yoshiki Y; Takatsu H; Ito K; Kamiya H; Yoshida Y; Murohara T; Izawa H;
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009314. PubMed ID: 33106049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Frequency Domain Optical Coherence Tomography Compared with Intravascular Ultrasound as a Guidance for Percutaneous Coronary Intervention.
    Kim IC; Yoon HJ; Shin ES; Kim MS; Park J; Cho YK; Park HS; Kim H; Nam CW; Han SW; Kim YN; Kim KB; Hur SH
    J Interv Cardiol; 2016 Apr; 29(2):216-24. PubMed ID: 26927366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Miyazawa A; Watanabe H; Natsuaki M; Watanabe H; Yamaji K; Ohya M; Nakamura S; Mitomo S; Suwa S; Domei T; Tatsushima S; Ono K; Sakamoto H; Shimamura K; Shigetoshi M; Taniguchi R; Nishimoto Y; Okayama H; Matsuda K; Yokomatsu T; Muto M; Kawaguchi R; Kishi K; Hadase M; Fujita T; Nishida Y; Nishino M; Otake H; Suematsu N; Ajimi T; Tanabe K; Abe M; Hibi K; Kadota K; Ando K; Kimura T;
    Circ Cardiovasc Interv; 2023 May; 16(5):e012922. PubMed ID: 37192307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
    Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; Xu K; Parise H; Mehran R; Mintz GS; Stone GW
    Circulation; 2014 Jan; 129(4):463-70. PubMed ID: 24281330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.
    Silber S; Windecker S; Vranckx P; Serruys PW;
    Lancet; 2011 Apr; 377(9773):1241-7. PubMed ID: 21459430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.
    Choi KH; Song YB; Lee JM; Lee SY; Park TK; Yang JH; Choi JH; Choi SH; Gwon HC; Hahn JY
    JACC Cardiovasc Interv; 2019 Apr; 12(7):607-620. PubMed ID: 30878474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Optimizing Outcomes in Acute Myocardial Infarction.
    Kim Y; Bae S; Johnson TW; Son NH; Sim DS; Hong YJ; Kim SW; Cho DK; Kim JS; Kim BK; Choi D; Hong MK; Jang Y; Jeong MH;
    J Am Heart Assoc; 2022 Mar; 11(5):e023481. PubMed ID: 35179041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.
    Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
    Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial.
    Lee JM; Park SD; Lim SY; Doh JH; Cho JM; Kim KS; Bae JW; Chung WY; Youn TJ
    Trials; 2013 Nov; 14():398. PubMed ID: 24257456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Siddiqi TJ; Khan MS; Karimi Galougahi K; Shlofmitz E; Moses JW; Rao S; West NEJ; Wolff E; Hochler J; Chau K; Khalique O; Shlofmitz RA; Jeremias A; Ali ZA
    Catheter Cardiovasc Interv; 2022 Nov; 100 Suppl 1():S44-S56. PubMed ID: 36251325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.